1060816-58-1

Basic information

• Product Name: 5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine
• Synonyms: 5-BroMo-2-chloro-7H-pyrro...;5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine
• CAS NO: 1060816-58-1
• Molecular Formula: C₆H₃BrClN₃
• Molecular Weight: 232.46512
• Product Categories: Heterocycle-Pyrimidine series
• Mol File: 1060816-58-1.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.996 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.51±0.50(Predicted)
• CAS DataBase Reference: 5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine(1060816-58-1)
• EPA Substance Registry System: 5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine(1060816-58-1)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 1060816-58-1(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine is a specialized chemical compound that contains bromine (Br), chlorine (Cl), and pyrrolopyrimidine, an organic component classified as a hydrochloride. In chemical notation, it can also be represented as C6H3BrClN3. It belongs to the subclass of organic compounds known as pyrrolo[2,3-d]pyrimidines, which are compounds containing a pyrrolo[2,3-d]pyrimidine moiety, which consists of a pyrrole ring fused to a pyrimidine ring. This chemical is used mainly for research purposes, particularly in creating new active pharmaceutical ingredients. It should be handled with care due to its potentially reactive properties.

Upstream product

• 335654-06-3 2-chloro-7H-pyrrolo[2,3-d]pyrimidine 

Downstream Products

• 1429881-91-3 trans-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexan-1-ol 
• 1392804-15-7 5-bromo-7-(trans-4-((tert-butyldimethylsilyl)oxy)cyclohexyl)-2-chloro-7H-pyrrolo[2,3-d]pyrimidine 

Relevant articles and documents

Tricyclic kinase inhibitors

The invention belongs to the technical field of medicines, and particularly relates to tricyclic DNA-PK kinase inhibitor compounds as shown in a general formula (I), pharmaceutically acceptable salts or isomers thereof, a pharmaceutical composition and prepartion containing the compounds, the pharmaceutically acceptable salts or the isomers thereof, a method for preparing the compound and the pharmaceutically acceptable salts or isomers thereof, and uses of the compounds and pharmaceutically acceptable salts or isomers thereof.

Preparation method of 5-bromo-2-chloro-7H-pyrrolo [2, 3-d] pyrimidine

The invention discloses a preparation method of 5-bromo-2-chloro-7H-pyrrolo[2, 3-b] pyridine. According to the method, 2,4-chloro-7H-pyrrolo[2, 3-d] pyrimidine is used as a starting raw material, in the presence of zinc powder and acetic acid, selective d

Preparation method of MER/FLT3 dual-inhibitor intermediate

The invention discloses a preparation method of an MER/FLT3 dual-inhibitor intermediate, namely, trans-4(5-bromo-2-chloro-7H-pyrrole[2,3-d] pyrimidine-7-yl)-cyclohexanol. The preparation method comprises steps as follows: a compound II is taken as a raw m